OmniAb, Inc. OABI
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2020-10-09
Chart by TradingView
1/9
Piotroski F — financial health
6
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $18.7M | $26.4M | $34.2M | $59.1M | $34.7M |
| Operating income | -$69.0M | -$74.5M | -$69.4M | -$26.6M | -$35.6M |
| Net income | -$64.8M | -$62.0M | -$50.6M | -$22.3M | -$27.0M |
| Operating cash flow | -$36.5M | -$39.7M | $2.3M | -$3.6M | -$5.7M |
| Free cash flow | -$37.0M | -$41.5M | $703,000 | -$20.8M | -$9.7M |
| Total assets | $300.9M | $325.6M | $375.2M | $421.2M | $304.5M |
| Total liabilities | $33.9M | $37.9M | $60.6M | $79.8M | $70.2M |
| Shareholders' equity | $267.0M | $287.6M | $314.6M | $341.4M | $234.3M |
| Ratios | |||||
| Operating margin | -369.5% | -282.3% | -203.2% | -45.1% | -102.5% |
| Net margin | -347.0% | -235.1% | -148.2% | -37.8% | -77.8% |
| FCF margin | -198.3% | -157.4% | 2.1% | -35.1% | -28.0% |
| Return on assets | -21.5% | -19.1% | -13.5% | -5.3% | -8.9% |
| Return on equity | -24.3% | -21.6% | -16.1% | -6.5% | -11.5% |
| Current ratio | 4.02 | 4.52 | 4.11 | 4.80 | 1.10 |
| Revenue growth | -29.3% | -22.8% | -42.2% | 70.0% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 269,600 | $423,272 |
| Point72 Asset Management, L.P. | 16,238 | $25,494 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6 (safe)
- Working capital / assets 0.163
- Retained earnings / assets -0.552
- EBIT / assets -0.229
- Equity / liabilities 7.88
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001846253 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.